Porcia A. Thurston

Associate Director, Contracts Specialist | She/Her/Hers

Overview

Porcia Thurston brings over 16 years of experience in the biopharmaceutical industry  to her work for clients.

She leverages her prior in-house experience to skillfully and pragmatically draft, negotiate, and manage agreements for a wide range of research and clinical development matters, including study start-up and complex master services agreements, site agreements, data privacy agreements, and informed consents for large, multinational clinical studies of therapeutic products.

Porcia has donated time to Feed the Hood, a program that is part of the East Oakland Collective, a non-profit organization in Oakland, California dedicated to helping community members of East Oakland. Porcia has also volunteered with the California Reentry Program, a non-profit organization dedicated to helping formerly incarcerated individuals in San Quentin State Prison successfully reenter into society.

While in law school, Porcia volunteered at a non-profit organization called Safe Streets Strong Communities in New Orleans following Hurricane Katrina, and served as the General Relief Advocacy Program (GRAP) chairperson, assisting those in need of obtaining public benefits at various Department of Social Services locations around Los Angeles, California.

Career & Education

    • Clinical Contracts and Finance Associate, Gilead Sciences, Inc.
        • Reviewed, drafted, negotiated and managed a variety of clinical trial agreements, amendments, and assignment agreements
        • Worked in project management of clinical trials
    • Clinical Contracts and Finance Associate, Gilead Sciences, Inc.
        • Reviewed, drafted, negotiated and managed a variety of clinical trial agreements, amendments, and assignment agreements
        • Worked in project management of clinical trials
    • University of California, Los Angeles, B.S., magna cum laude, Political Science
    • University of California, Los Angeles, J.D., Critical Race Studies
    • University of California, Los Angeles, B.S., magna cum laude, Political Science
    • University of California, Los Angeles, J.D., Critical Race Studies

Representative Matters

  • Drafted, negotiated, and coordinated clinical trial and related agreements for multiple clinical trials of precision medicine therapeutics, including phase 2/3 trials involving over 80 sites in North America, Europe, and Asia.
  • Drafted, negotiated, and coordinated clinical trial and related templates and agreements for multiple clinical trials of a bifunctional monoclonal antibody that targets B cells for multiple autoimmune diseases, including phase 3 trials involving over 100 sites in North America, South America, Europe, and Asia.
  • Drafted, negotiated, and managed clinical trial templates and related agreements for a Phase 2 cardiovascular clinical trial of a PDE9 inhibitor involving approximately 145 sites in Western and Eastern Europe.
  • Drafted, negotiated, and coordinated multiple Phase 2 clinical trials of an aurora kinase inhibitor involving over 60 sites in the U.S. and Europe.
  • Drafted and negotiated agreements with service providers for clinical and preclinical studies of therapeutic and medical device products, including multi-million-dollar master services agreements with large global research organizations.